The item has been added to your shopping cart.
Home » SERONO ENROLLING US PATIENTS TO ORAL MS DRUG TRIAL
SERONO ENROLLING US PATIENTS TO ORAL MS DRUG TRIAL
Serono is in a race with other companies, including Swiss peer Novartis AG (NVS), to bring the first oral MS drug to the market. Oral cladribine is also known under its suggested brand name Mylinax.
Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=886254&contentType=sentryarticle&channelID=30)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct